Legacy Capital Wealth Partners LLC Sells 1,926 Shares of Integer Holdings Co. (NYSE:ITGR)

Legacy Capital Wealth Partners LLC lowered its stake in Integer Holdings Co. (NYSE:ITGR - Free Report) by 52.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,762 shares of the medical equipment provider's stock after selling 1,926 shares during the period. Legacy Capital Wealth Partners LLC's holdings in Integer were worth $234,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Mather Group LLC. grew its holdings in Integer by 304.3% during the 4th quarter. Mather Group LLC. now owns 190 shares of the medical equipment provider's stock worth $25,000 after acquiring an additional 143 shares during the period. Huntington National Bank grew its holdings in Integer by 8,933.3% during the 3rd quarter. Huntington National Bank now owns 271 shares of the medical equipment provider's stock worth $35,000 after acquiring an additional 268 shares during the period. R Squared Ltd acquired a new stake in Integer during the 4th quarter worth $44,000. Versant Capital Management Inc grew its holdings in Integer by 98.4% during the 4th quarter. Versant Capital Management Inc now owns 369 shares of the medical equipment provider's stock worth $49,000 after acquiring an additional 183 shares during the period. Finally, Contravisory Investment Management Inc. grew its holdings in Integer by 210.8% during the 4th quarter. Contravisory Investment Management Inc. now owns 693 shares of the medical equipment provider's stock worth $92,000 after acquiring an additional 470 shares during the period. Institutional investors and hedge funds own 99.29% of the company's stock.

Integer Stock Down 3.9 %

ITGR traded down $5.26 during trading on Friday, hitting $129.96. The company had a trading volume of 499,343 shares, compared to its average volume of 252,248. The company has a market capitalization of $4.36 billion, a PE ratio of 40.11, a PEG ratio of 1.82 and a beta of 1.13. Integer Holdings Co. has a one year low of $98.63 and a one year high of $146.36. The firm's 50-day moving average price is $137.92 and its 200 day moving average price is $132.31. The company has a quick ratio of 2.09, a current ratio of 3.28 and a debt-to-equity ratio of 0.67.

Integer (NYSE:ITGR - Get Free Report) last posted its quarterly earnings data on Thursday, February 20th. The medical equipment provider reported $1.43 EPS for the quarter, missing the consensus estimate of $1.46 by ($0.03). Integer had a net margin of 6.70% and a return on equity of 11.63%. The company had revenue of $449.50 million during the quarter, compared to the consensus estimate of $446.28 million. As a group, equities analysts expect that Integer Holdings Co. will post 5.33 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of analysts have commented on ITGR shares. Truist Financial lifted their target price on shares of Integer from $147.00 to $163.00 and gave the stock a "buy" rating in a report on Wednesday, December 11th. Wells Fargo & Company reissued an "overweight" rating and issued a $160.00 price target on shares of Integer in a report on Tuesday, December 3rd. Benchmark boosted their price target on shares of Integer from $140.00 to $150.00 and gave the company a "buy" rating in a report on Friday. Oppenheimer lowered shares of Integer from an "outperform" rating to a "market perform" rating in a report on Friday. Finally, Citigroup boosted their price target on shares of Integer from $130.00 to $145.00 and gave the company a "neutral" rating in a report on Wednesday, December 11th. Two research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat, Integer has an average rating of "Moderate Buy" and a consensus target price of $147.67.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.